Characterization of carbapenem-resistant acinetobacter calcoaceticus–baumannii complex isolates from nosocomial bloodstream infections in Southern Iran

Journal of Medical Microbiology

Volumn 65, Issue 3, 2016, Pages 235-239

  Pourabbas, Bahman ^a   Firouzi, Roya ^a   Pouladfar, Gholamreza ^b  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BACTERIAL PROTEIN; BLAOXA 23 LIKE PROTEIN; BLAOXA 51 LIKE PROTEIN; BLAOXA 58 LIKE PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENOMIC DNA; GENTAMICIN; IMIPENEM; IMP PROTEIN; ISABA1 PROTEIN; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RIFAMPICIN; SULTAMICILLIN; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX; ACINETOBACTER INFECTION; ACINETOBACTER JUNII; ACINETOBACTER NOSOCOMIALIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CARBAPENEM RESISTANT ACINETOBACTER CALCOACETICUS BAUMANNII COMPLEX; HOSPITAL INFECTION; HUMAN; IRAN; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPECIES DISTRIBUTION; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; GENOTYPE; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYSIOLOGY;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VARIATION; GENOTYPE; HUMANS; IRAN;

EID: 84960813440     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000219     Document Type: Article

References (31)

1. Bergogne-Bérézin, E. & Towner, K. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148–165.
2. Bonnin, R. A., Docobo-Pérez, F., Poirel, L., Villegas, M. V. & Nordmann, P. (2014). Emergence of OXA-72-producing Acinetobacter pittii clinical isolates. Int J Antimicrob Agents 43, 195–196.
3. Boo, T. W., Walsh, F. & Crowley, B. (2006). First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic. J Antimicrob Chemother 58, 1101–1102.
4. Boo, T. W., Walsh, F. & Crowley, B. (2009). Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol 58, 209–216.
5. CLSI (2014). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Ellington, M. J., Kistler, J., Livermore, D. M. & Woodford, N. (2007). Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 59, 321–322.
7. Evans, B. A., Hamouda, A., Towner, K. J. & Amyes, S. G. (2010). Novel genetic context of multiple bla OXA-58 genes in Acinetobacter genospecies 3. J Antimicrob Chemother 65, 1586–1588.
8. Gerner-Smidt, P., Tjernberg, I. & Ursing, J. (1991). Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 29, 277–282.
9. Gundi, V. A., Dijkshoorn, L., Burignat, S., Raoult, D. & La Scola, B. (2009). Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155, 2333–2341.
10. Higgins, P. G., Lehmann, M., Wisplinghoff, H. & Seifert, H. (2010). gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 48, 4592–4594.
11. Japoni, S., Farshad, S., Abdi Ali, A. & Japoni, A. (2011). Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran. Iran Red Crescent Med J 13, 832–836.
12. Kim, D. H., Choi, J. Y., Jung, S. I., Thamlikitkul, V., Song, J. H. & Ko, K. S. (2012). AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates. Antimicrob Agents Chemother 56, 4548–4549.
13. Lee, Y. T., Kuo, S. C., Chiang, M. C., Yang, S. P., Chen, C. P., Chen, T. L. & Fung, C. P. (2012). Emergence of carbapenem-resistant nonbaumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother 56, 1124–1127.
14. Lim, Y. M., Shin, K. S. & Kim, J. (2007). Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J ClinMicrobiol 45, 902–905.
15. Magiorakos, A.P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G. & other authors (2012). Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18, 268–281.
16. Martín-Lozano, D., Cisneros, J. M., Becerril, B., Cuberos, L., Prados, T., Ortíz-Leyba, C., Cañas, E. & Pachón, J. (2002). Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol 40, 4571–4575.
17. Mendes, R. E., Farrell, D. J., Sader, H. S. & Jones, R. N. (2010). Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009). Diagn Microbiol Infect Dis 68, 307–311.
18. Navon-Venezia, S., Ben-Ami, R. & Carmeli, Y. (2005). Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18, 306–313.
19. Nemec, A., Krizova, L., Maixnerova, M., van der Reijden, T. J. K., Deschaght, P., Passet, V., Vaneechoutte, M., Brisse, S. & Dijkshoorn, L. (2011). Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162, 393–404.
20. Peleg, A. Y., Franklin, C., Walters, L. J., Bell, J. M. & Spelman, D. W. (2006). OXA-58 and IMP-4 carbapenem-hydrolyzing betalactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother 50, 399–400.
21. Poirel, L. & Nordmann, P. (2006).Carbapenemresistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12, 826–836.
22. Segal, H., Garny, S. & Elisha, B. G. (2005). Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol Lett 243, 425–429.
23. Teixeira, A. B., Martins, A. F., Barin, J., Hermes, D. M., Pitt, C. P. & Barth, A. L. (2013). First report of carbapenem-resistant Acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America. J Clin Microbiol 51, 2739–2741.
24. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M. & Pitt, T. L. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258, 72–77.
25. van den Broek, P. J., van der Reijden, T. J., van Strijen, E., Helmig-Schurter, A. V., Bernards, A. T. & Dijkshoorn, L. (2009). Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey. J Clin Microbiol 47, 3593–3599.
26. Wang, H., Guo, P., Sun, H., Wang, H., Yang, Q., Chen, M., Xu, Y. & Zhu, Y. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 51, 4022–4028.
27. Wisplinghoff, H., Edmond, M.B., Pfaller, M. A., Jones, R.N., Wenzel, R. P. & Seifert, H. (2000). Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 31, 690–697.
28. Wisplinghoff, H., Paulus, T., Lugenheim, M., Stefanik, D., Higgins, P.G., Edmond, M. B., Wenzel, R. P. & Seifert, H. (2012). Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect 64, 282–290.
29. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351–353.
30. Zarrilli, R., Giannouli, M., Tomasone, F., Triassi, M. & Tsakris, A. (2009). Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries 3, 335–341.
31. Zavascki, A. P., Carvalhaes, C. G., Picão, R. C. & Gales, A. C. (2010). Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther 8, 71–93.